| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 15.138 | 3.307 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 15.138 | 3.348 | 0 |
| Total Expenses - EUR | - | - | - | - | - | - | 0 | 6.072 | 3.588 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 0 | 9.065 | -240 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 0 | 8.692 | -288 | 0 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuromaze S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 40 | 9.290 | 8.505 | 8.371 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 92 | 0 | 0 |
| Cash | - | - | - | - | - | - | 40 | 9.198 | 8.505 | 8.370 |
| Shareholders Funds | - | - | - | - | - | - | 40 | 8.732 | 8.418 | 8.371 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 0 | 558 | 87 | 0 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuromaze S.r.l.